ProductLife Group Has Consolidated 26 Businesses

The firm unveiled a new brand identity, PLG Advanced Intelligence for Life Sciences, to unify its global operations.

Updated on Sept. 29, 2026 in Business Strategy

Isometric editorial illustration of interlocking geometric architectural blocks, representing the consolidation of a complex international business structure.
ProductLife Group has consolidated 26 previously acquired businesses into a single unified entity, rebranding as PLG Advanced Intelligence for Life Sciences. AI Illustration. Upload story photo >

Live Poll

Do you trust that merging many small companies into one unified group improves service quality?

ProductLife Group has finalized the consolidation of 26 businesses acquired over the past six years into a single unified organization. The company also launched a new brand identity, PLG Advanced Intelligence for Life Sciences, to support its international life sciences services.

Why it matters

By unifying its diverse acquisitions under one brand, the group intends to leverage combined human expertise and intelligent automation to accelerate the therapy development process for its global client base.

The organization now operates across 50 countries with a team of 1,750 experts representing 60 different nationalities. The firm maintains a reach into 150 countries through its network of partners and has served a total of 2,000 clients.

The players

ProductLife Group

This life sciences service provider operates globally to support therapy development through development, market access, and compliance units.

21 Invest

This private equity firm provides capital and strategic support to middle-market European companies.

Oakley Capital

This private equity investor focuses on providing growth capital to mid-market companies in sectors like technology and consumer brands.

The details

The newly branded entity is structured into four core business units focusing on development, market access, compliance, and digital innovation. The organization remains backed by private equity firms 21 Invest and Oakley Capital as it executes its buy-and-build strategy.

Timeline

  1. The 26 acquisitions took place between 2020 and 2026.

  2. The new brand and website were officially launched on September 29, 2026.

  3. Full group integration is scheduled for completion by the end of 2027.

Market Landscape

This consolidation follows a pattern set by the buy-and-build private equity strategy, where firms acquire niche players to create a single, vertically integrated platform. Such movements are typical in the life sciences sector as companies race to achieve the scale necessary for global market access.

Clients of the firm can expect more streamlined service delivery as the organization integrates its four specialized business units under a single brand identity. This unified structure aims to provide a more consistent experience across international markets.

The takeaway

The move demonstrates the increasing importance of scale and digital integration in the highly regulated life sciences industry. Businesses in this sector continue to use aggressive acquisition strategies to consolidate specialized expertise into comprehensive service platforms.

What happens next

Full integration across the various business units is scheduled to be finalized by the end of 2027.

Further reading

Learn more about the Business Strategy that drives corporate consolidation in the life sciences sector.

More information

View the company's service offerings on the new corporate website.

Live Poll

Do you trust that merging many small companies into one unified group improves service quality?